Medtronic targets developing markets with 15,000-patient pacemaker study
This article was originally published in Clinica
Executive Summary
Medtronic has started a large-scale study in developing countries on the impact of education on the diagnosis and treatment of patients with sinus node dysfunction (SND), a type of heart disorder. The disease leads to an abnormal heartbeat or arrhythmia, which can be treated with implanted pacemakers.